Home › Oropharyngeal Cancer › Illinois › Aurora
Oropharyngeal Cancer clinical trials in Aurora, IL
3 studies for Oropharyngeal Cancer are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Rush-Copley Medical Center, Aurora
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi away
- Rush-Copley Healthcare Center, Yorkville · 11 mi away
- and 1 more
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi away
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi away
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville · 11 mi away
Oropharyngeal Cancer trials in other cities
- Atlanta, GA8 studies
- Edison, NJ8 studies
- Chicago, IL7 studies
- New York City, NY6 studies
- Queens, NY5 studies
- St. Louis, MO5 studies
- Tampa, FL5 studies
- Kansas City, MO5 studies
- Pittsburgh, PA5 studies
- Milwaukee, WI5 studies
- Omaha, NE5 studies
- Philadelphia, PA5 studies
Other studies in Aurora
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer11 studies
- Prostate Cancer9 studies
- Melanoma7 studies
- Breast Cancer7 studies
- Ovarian Cancer5 studies
- Head and Neck Squamous Cell Carcinoma5 studies
- Cancer (all types)4 studies
- Acute Myeloid Leukemia4 studies
- Pancreatic Cancer4 studies
- Hypopharyngeal Cancer4 studies
- Laryngeal Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.